Skip to Main Content

Paper Details

Prediction and clinical utility of a contralateral breast cancer risk model.
Breast Cancer Res
25
2019
BRCA1, BRCA1/2, BRCA1/2 germline mutation, BRCA1/2 mutation, Breast cancer, CBC, breast cancer, contralateral breast cancer, non-metastatic breast cancer, patient, patients, women
Author NameAffiliation
Ewout W SteyerbergLeiden University Medical Center
Ewout W SteyerbergErasmus MC Cancer Institute
Jenny Chang-ClaudeGerman Cancer Research Center (DKFZ)
Jenny Chang-ClaudeUniversity Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf
Alison M DunningUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Douglas F EastonUniversity of Cambridge
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine
Peter A FaschingComprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg
Jonine D FigueroaThe University of Edinburgh Medical School
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Jonine D Figueroa
Jonine D FigueroaThe University of Edinburgh Medical School
Jonine D Figueroa
Jonine D FigueroaNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasInstitute of Cancer Research
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasInstitute of Cancer Research
Christopher A HaimanKeck School of Medicine, University of Southern California
Christopher A HaimanKeck School of Medicine, University of Southern California
Per HallKarolinska Institute
Per Hall
Diether LambrechtsVIB Center for Cancer Biology
Diether LambrechtsUniversity of Leuven
Loic Le MarchandUniversity of Hawaii Cancer Center
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Paul D P PharoahUniversity of Cambridge
Carolien H M van DeurzenErasmus MC Cancer Institute
  • 1 - 33

Datasets